Protocol Ledger

NCT03978000 · Phase III · ACTIVE NOT RECRUITING

IBP-9414 for the Prevention of Necrotizing Enterocolitis - The Connection Study

Interventional Phase III clinical trial protocol NCT03978000 sponsored by Infant Bacterial Therapeutics in Rare Genetic, Women's Health, and Other, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2019-07-04 Enrollment: 2,158 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT03978000
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)2,158 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT03978000
Protocol FieldVerified Registry Value
NCT IdentifierNCT03978000
Consolidated Lead SponsorInfant Bacterial Therapeutics
Therapeutic Condition CohortRare Genetic, Women's Health, and Other
Clinical Trial PhasePhase III
Overall Recruitment StatusACTIVE NOT RECRUITING
Registered Enrollment2,158 participants (ACTUAL)
Registered Start Date2019-07-04
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI